Form 4 for OFIX Orthofix Medical Inc.
Accepted 2025-05-12 00:00:00 ET · period of report 2025-05-09 · accession 0000950170-25-069583 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-12 | 2025-05-09 | OFIX | Calafiore Massimo | Pres, CEO, Dir | P - Purchase | $12.54 | +10.0K | 234.6K | +4% | +$125.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-09 | P | A | 10,000 | $12.54 | 234,603 | D | — | — | (F1) Reflects the weighted average purchase price. The range of prices for these transactions was $12.41 to $12.755. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes 182,396 previously reported restricted stock units and 2,199 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025. |